Budesonide; Formoterol Fumarate; Glycopyrrolate Patent Expiration

Budesonide; Formoterol Fumarate; Glycopyrrolate is Used for managing chronic obstructive pulmonary disease (COPD). It was first introduced by Astrazeneca Ab in its drug Breztri Aerosphere on Jul 23, 2020.


Budesonide; Formoterol Fumarate; Glycopyrrolate Patents

Given below is the list of patents protecting Budesonide; Formoterol Fumarate; Glycopyrrolate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Breztri Aerosphere US11331442 Drug delivery systems and related methods Oct 05, 2038 Astrazeneca Ab
Breztri Aerosphere US11833292 Drug delivery systems and related methods Oct 05, 2038 Astrazeneca Ab
Breztri Aerosphere US8815258 Compositions, methods and systems for respiratory delivery of two or more active agents Mar 17, 2031 Astrazeneca Ab
Breztri Aerosphere US10716753 Compositions for pulmonary delivery of long-acting muscarinic antagonists or long-acting B2 adrenergic receptor agonists and associated methods and systems May 28, 2030 Astrazeneca Ab
Breztri Aerosphere US8324266 Compositions, methods and systems for respiratory delivery of two or more active agents May 28, 2030 Astrazeneca Ab
Breztri Aerosphere US8703806 Compositions, methods and propellant-based systems for respiratory delivery of glycopyrrolate and one or more active agents May 28, 2030 Astrazeneca Ab
Breztri Aerosphere US8808713 Compositions for pulmonary delivery of long-acting β2 adrenergic receptor agonists and associated methods and systems May 28, 2030 Astrazeneca Ab
Breztri Aerosphere US9415009 Compositions, methods and systems for respiratory delivery of two or more active agents May 28, 2030 Astrazeneca Ab
Breztri Aerosphere US9463161 Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems May 28, 2030 Astrazeneca Ab



Budesonide; Formoterol Fumarate; Glycopyrrolate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List